PRNewswire/ - MolecuLight today announced that its MolecuLightDX(R) wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The ...

MolecuLight today announced that its MolecuLightDX wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical ...

DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Digital Wound Measurement Devices Market (2018 - 2024)" report has been added to ResearchAndMarkets.com's offering. The Asia Pacific Digital Wound ...

According to a new market research study on “North America Digital Wound Measurement Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Type of Wound, Application, ...

The MolecuLightDX now provides its users with a complete wound measurement solution allowing clinicians to digitally measure wound area, length, width and depth with a single image capture and without ...

i:X Platform's Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds TORONTO, Feb. 20, 2020 /CNW/ - MolecuLight Inc., the world's ...

PITTSBURGH, Oct. 1, 2024 /PRNewswire/ - MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, announced ...